Design 制药 DSGN
$10.21 +$0.54 (+5.58%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $10.21 0.00%
开盘$9.73
昨收$9.67
当日区间$9.70 – $10.34
成交量330.6K
市值$653.81M
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数3
平均目标价$22.67+122.0% 较现价
- 买入 100%
最低 $20.00现价 $10.21均值 $22.67最高 $26.00
最新评级变动
已记录的最近19次评级动作给出的目标价区间为$13.00至$26.00，平均为$18.68。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 12 Oct 2026 | Wells Fargo | BUY | $26.00 |
| 2 Oct 2026 | Wells Fargo | BUY | $26.00 |
| 4 Aug 2026 | Craig-Hallum | BUY | $22.00 |
| 3 Aug 2026 | RBC Capital | BUY | $20.00 |
| 15 Jun 2026 | Oppenheimer | BUY | $21.00 |
| 27 May 2026 | Piper Sandler | BUY | $20.00 |
| 19 May 2026 | Craig-Hallum | BUY | $22.00 |
| 18 May 2026 | RBC Capital | BUY | $20.00 |
| 4 May 2026 | Oppenheimer | BUY | $21.00 |
| 29 Apr 2026 | Craig-Hallum | BUY | $15.00 |
| 29 Apr 2026 | Piper Sandler | BUY | $20.00 |
| 28 Apr 2026 | RBC Capital | BUY | $14.00 |
| 15 Mar 2026 | Jefferies | BUY | $15.00 |
| 10 Mar 2026 | Craig-Hallum | BUY | $15.00 |
| 10 Mar 2026 | Oppenheimer | BUY | $18.00 |
| 7 Jan 2026 | Oppenheimer | BUY | $18.00 |
| 3 Dec 2025 | Craig-Hallum | BUY | $15.00 |
| 3 Dec 2025 | Leerink Partners | BUY | $14.00 |
| 20 Nov 2025 | RBC Capital | BUY | $13.00 |
暂无评论——快来第一个聊聊 DSGN。
登录后参与讨论。